|
Nanomix and UCLA Sign Exclusive Licensing Agreement
Developing Nano-based DNA Detection Platform
Emeryville, CA - December 9, 2004 -
Nanomix
Inc., a leading nanotechnology company, today announced that it has signed
an exclusive licensing agreement with The Regents of the University of
California, Los Angeles, for technology used to detect biomolecules such as
DNA and proteins. The licensing agreement gives Nanomix the right to use and
further develop the technology, invented by Dr. George Gruner of UCLA.
Future applications of this promising technology may range from glucose
monitoring to viral and infectious disease detection and even homeland
security.
"We are very excited to be licensing partners with UCLA, helping to advance
our biomolecule detection platform," said David Macdonald, CEO and President
of Nanomix. "Dr. Gruner's discoveries will be used to develop products
including a range of sensors and detectors for medical, diagnostic,
industrial and forensic uses. These sensors will permit the direct
electronic detection and identification of biomolecules, resulting in
faster, simpler and cheaper measurements."
"Electronic detection of biomolecules, the subject of the licensed invention
will likely play a significant role in a variety of products in the
biomedical and biotechnology arena, ranging from early detection of cancer
to gene chips," said Dr. George Gruner. "I anticipate that Nanomix will
pursue a vigorous research and development program that will move the
invention from the early-stage feasibility study to a product development
phase."
The license includes a pending patent application by Dr. Gruner (Publication
No.: US 2004-0067,530), describing nano-structured electronic devices which
include biological probe molecules. The probe molecules produce a measurable
electrical effect when binding or interacting with a target biological
molecule.
About Nanomix
Nanomix is an exciting nanotechnology company currently launching a menu of
nanoelectronic detection devices combining carbon nanotube electronics with
silicon microstructures. These sensors will add value across a broad range
of industrial and medical applications where attributes of nanotechnology --
low power consumption, small size, high sensitivity, specificity,
reproducibility, and wireless system integration offer significant
performance advantages. Founded in 2000, Nanomix is located in Emeryville,
California. For additional information, please visit
www.nano.com or email
info@nano.com.
G. Grüner Nano-Biophysics Group Homepage | UCLA
Department of Physics & Astronomy |